A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma

Abstract Background Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B). However, it often leads to a poor prognosis and decreased hepatic function especially in patients with BCLC substage B2...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Satoshi Moriya, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Shunji Hirose, Tatehiro Kagawa, Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Michihiro Suzuki, Haruki Uojima, Hisashi Hidaka, Chika Kusano, Motoko Suzuki, Manabu Morimoto
格式: Artigo
語言:Inglês
出版: BMC 2022-05-01
叢編:BMC Cancer
主題:
Hepatocellular carcinoma
Intermediate stage
Substage
Lenvatinib
TACE
在線閱讀:https://doi.org/10.1186/s12885-022-09625-x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍